Free Trial

XTX Topco Ltd Acquires New Stake in Astrana Health, Inc. (NASDAQ:ASTH)

Astrana Health logo with Medical background

XTX Topco Ltd purchased a new stake in shares of Astrana Health, Inc. (NASDAQ:ASTH - Free Report) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 18,188 shares of the company's stock, valued at approximately $564,000.

Several other large investors have also recently added to or reduced their stakes in ASTH. Quarry LP grew its stake in Astrana Health by 35.5% during the 4th quarter. Quarry LP now owns 1,799 shares of the company's stock worth $57,000 after buying an additional 471 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in shares of Astrana Health by 3.9% during the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 24,505 shares of the company's stock valued at $773,000 after acquiring an additional 915 shares during the period. MetLife Investment Management LLC grew its position in shares of Astrana Health by 4.7% during the fourth quarter. MetLife Investment Management LLC now owns 26,284 shares of the company's stock worth $829,000 after acquiring an additional 1,173 shares during the last quarter. Envestnet Asset Management Inc. increased its holdings in shares of Astrana Health by 19.9% in the 4th quarter. Envestnet Asset Management Inc. now owns 7,124 shares of the company's stock worth $225,000 after acquiring an additional 1,184 shares during the period. Finally, Pictet Asset Management Holding SA lifted its position in Astrana Health by 21.9% in the 4th quarter. Pictet Asset Management Holding SA now owns 7,075 shares of the company's stock valued at $223,000 after purchasing an additional 1,273 shares during the last quarter. 52.77% of the stock is currently owned by institutional investors.

Astrana Health Stock Performance

Shares of NASDAQ:ASTH traded down $0.35 during trading hours on Thursday, hitting $21.46. The stock had a trading volume of 457,588 shares, compared to its average volume of 358,975. The stock's fifty day simple moving average is $24.38 and its 200 day simple moving average is $29.27. The firm has a market capitalization of $1.20 billion, a price-to-earnings ratio of 29.81, a PEG ratio of 0.80 and a beta of 0.85. The company has a debt-to-equity ratio of 0.54, a quick ratio of 1.70 and a current ratio of 1.70. Astrana Health, Inc. has a 1-year low of $21.20 and a 1-year high of $63.20.

Astrana Health (NASDAQ:ASTH - Get Free Report) last posted its earnings results on Thursday, August 7th. The company reported $0.19 EPS for the quarter, missing the consensus estimate of $0.36 by ($0.17). Astrana Health had a net margin of 1.56% and a return on equity of 4.90%. The company's revenue for the quarter was up 34.7% compared to the same quarter last year. During the same period last year, the firm earned $0.40 earnings per share. Sell-side analysts anticipate that Astrana Health, Inc. will post 1.15 earnings per share for the current fiscal year.

Astrana Health Company Profile

(Free Report)

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.

Further Reading

Institutional Ownership by Quarter for Astrana Health (NASDAQ:ASTH)

Should You Invest $1,000 in Astrana Health Right Now?

Before you consider Astrana Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astrana Health wasn't on the list.

While Astrana Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Quantum Boom: 3 Strong Picks with Lower Risk
3 Overlooked AI Stocks That Chipmakers Can’t Live Without
Palantir & AMD Earnings: Massive Options Setups Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines